Bailard’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-24,350
Closed -$2.28M – 844
2025
Q2
$2.28M Hold
24,350
– – 0.05% 227
2025
Q1
$2.57M Hold
24,350
– – 0.07% 205
2024
Q4
$2.36M Hold
24,350
– – 0.06% 205
2024
Q3
$2.41M Sell
24,350
-2,553
-9% -$234K 0.06% 213
2024
Q2
$2.31M Buy
26,903
+4,370
+19% +$344K 0.06% 210
2024
Q1
$1.71M Buy
22,533
+400
+2% +$30.9K 0.05% 243
2023
Q4
$1.68M Sell
22,133
-900
-4% -$62.8K 0.05% 233
2023
Q3
$1.59M Sell
23,033
-2,847
-11% -$205K 0.05% 222
2023
Q2
$2.16M Buy
25,880
+9,880
+62% +$804K 0.08% 187
2023
Q1
$1.18M Buy
16,000
+9,800
+158% +$688K 0.04% 244
2022
Q4
$438K Hold
6,200
– – 0.02% 430
2022
Q3
$350K Buy
+6,200
New +$357K 0.01% 434

Other funds holding MMSI

Bailard's MMSI Position: Q3 2025 in Review

Bailard sold out of Merit Medical Systems (MMSI) in Q3 2025, closing a stake of 24,350 shares — an estimated $2.28M sold.

Bailard first reported a position in MMSI in Q3 2022 and held it in 12 quarters. The position peaked at $2.57M in Q1 2025. 378 funds tracked by Wall St. Rank hold MMSI as of Q3 2025.

  • Bailard reported no remaining Merit Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Bailard sold 24,350 Merit Medical Systems shares in Q3 2025, an estimated $2.28M.
  • Bailard first reported a position in Merit Medical Systems in Q3 2022 and held it in 12 quarters.
  • Bailard's Merit Medical Systems position peaked at $2.57M in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2025.

Based on Bailard's 13F filing for Q3 2025, filed 30 Oct 2025.